The Childhood Arthritis and Rheumatology Research Alliance (CARRA) recently announced the current recipients of CARRA-Arthritis Foundation Grants, including Stephen Balevic, MD, MHS, assistant professor of pediatrics in the Division of Rheumatology. His project entitled, “Hydroxychloroquine Dosing and Pharmacokinetics in Pediatric Lupus,” has been funded from July 1, 2019 through June 30, 2020.
Research Summary: Active systemic lupus in children can result in long-term organ damage and disability. Hydroxychloroquine is a medication that improves disease activity in lupus and may help prevent long-term complications; however, the ideal dose of this medication in children is unknown. We propose to develop an optimal dosing strategy for hydroxychloroquine to improve the health of children who have systemic lupus.
CARRA’s mission is to conduct collaborative research to prevent, treat, and cure pediatric rheumatic diseases. The non-profit organization envisions a world free of limitations from pediatric rheumatic diseases.
For additional information, please visit the CARRA website.